| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/04/2013 | EP2668180A2 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same |
| 12/04/2013 | EP2668179A1 New 5-alkynyl-pyridines |
| 12/04/2013 | EP2668178A1 New 5-alkynyl-pyridines |
| 12/04/2013 | EP2668162A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses |
| 12/04/2013 | EP2667889A2 Wnt compositions and methods of use thereof |
| 12/04/2013 | EP2667871A1 Combinations |
| 12/04/2013 | EP2667868A2 Bendamustine formulations |
| 12/04/2013 | CN203315383U Nanometer anti-cancer medicament with radiotherapy function |
| 12/04/2013 | CN1701121B Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 12/04/2013 | CN1480212B Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 12/04/2013 | CN103429757A Cancer diagnosis and treatment |
| 12/04/2013 | CN103429737A Cytotoxicity-inducing therapeutic agent |
| 12/04/2013 | CN103429620A Stable heterodimeric antibody design with mutations in the Fc domain |
| 12/04/2013 | CN103429593A Imidazo pyrazines |
| 12/04/2013 | CN103429592A 6-substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment of hyperproliferative disorders |
| 12/04/2013 | CN103429591A 6 substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in treatment of hyperproliferative disorders |
| 12/04/2013 | CN103429586A Piperazinedione compounds |
| 12/04/2013 | CN103429583A Triazole derivatives as WNT signaling pathway inhibitors |
| 12/04/2013 | CN103429572A Tetrasubstituted cyclohexyl compounds as kinase inhibitors |
| 12/04/2013 | CN103429248A Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis |
| 12/04/2013 | CN103429238A Anticancer therapy with dual aurora kinase / MEK inhibitors |
| 12/04/2013 | CN103421887A Applications of CIT gene and relevant medicines |
| 12/04/2013 | CN103421886A Applications of CIZI gene and relevant medicines |
| 12/04/2013 | CN103421884A Applications of human FZR1 gene and related medicines of the human FZR1 gene |
| 12/04/2013 | CN103421874A Preparation and application of functional millet bran peptides |
| 12/04/2013 | CN103421796A siRNA (short interfering RNA) for reducing human OPN gene expression and related medicine thereof |
| 12/04/2013 | CN103421792A Method for inhibiting tumor cell growth by silencing eIF4H (Eukaryotic translation initiation factor 4H) and application of method |
| 12/04/2013 | CN103421738A Pharmacy applications of MTA1 and inhibitor thereof |
| 12/04/2013 | CN103421706A Streptomyces, novel compounds, preparation methods of novel compounds and application of novel compounds in preparing anti-bacterial drugs and antineoplastic drugs |
| 12/04/2013 | CN103421117A Immune-enhanced virus-like particles, expression vector thereof, and preparation and application thereof |
| 12/04/2013 | CN103421113A Anti-BLyS antibody |
| 12/04/2013 | CN103421109A Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
| 12/04/2013 | CN103421103A Lichiyong peptide, application thereof in preparation of drug for treating tumor, and preparation method of Lichiyong peptide |
| 12/04/2013 | CN103421102A Lichixiu peptide and application thereof in preparation of drug for treating tumor, and preparation method of Lichixiu peptide |
| 12/04/2013 | CN103421090A Novel antimicrobial peptide |
| 12/04/2013 | CN103421085A Oligopeptide used for increasing solubilities of paclitaxel or similar medicines based on paclitaxel structure |
| 12/04/2013 | CN103421083A Anti-dengue virus heterocycle peptide compounds having 1,2,3-triazole structure, preparation method and use thereof |
| 12/04/2013 | CN103421069A Fulvestrant phosphate derivative and preparation method and application thereof |
| 12/04/2013 | CN103421067A Double-target drug for anti-platelet aggregation and applications thereof |
| 12/04/2013 | CN103421061A Lenalidomide derivative and preparation method and pharmaceutical application thereof |
| 12/04/2013 | CN103421057A Combretastatin amino sugar conjugate and preparation method and medical appliance thereof |
| 12/04/2013 | CN103421048A Mono-chloride-dimethylsulfoxide-6-hydroxide radical oxidation iso-aporphine platinum (II) and synthesizing method and application thereof |
| 12/04/2013 | CN103421038A Double-tin-core coordination compound and preparing method thereof |
| 12/04/2013 | CN103421028A Vinorelbine derivative, medicine composition thereof, and preparation method and application of derivative and medicine composition |
| 12/04/2013 | CN103421027A Preparation method and application method of diazabicyclo compound |
| 12/04/2013 | CN103421021A Compound divorced from gamboge resin, derivative of compound, and pharmaceutical composition containing compound and derivative |
| 12/04/2013 | CN103421010A Pteridinone derivative as EGFR inhibitor and application thereof |
| 12/04/2013 | CN103421006A 2, 3, 5, 7-tetrasubstituted dihydro-pyrazolo piperidine derivative and preparation method and application thereof |
| 12/04/2013 | CN103421005A Acetylene derivative capable of resisting activity of tumor |
| 12/04/2013 | CN103420993A Thiophene substituent group-containing compound as well as preparation method and application thereof |
| 12/04/2013 | CN103420990A 7-oxy, thio or imino substituted coumarin, and derivatives and applications thereof |
| 12/04/2013 | CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 12/04/2013 | CN103420986A Compound replacing quinoidines as well as using method and application of compound |
| 12/04/2013 | CN103420977A Acetylene derivative with anti-tumor activity |
| 12/04/2013 | CN103420971A Antitumor compounds derived from G. nujiangnsis, and preparation method and application thereof |
| 12/04/2013 | CN103420963A Costunolide derivative and pharmaceutical composition, preparation method and uses thereof |
| 12/04/2013 | CN103420925A Polymorphs of derivatives of 4-aniline quinazoline and manufacturing method and application thereof |
| 12/04/2013 | CN103420923A 4-aminoquinazolinehydroxamic acid compounds and applications thereof as antitumor medicaments |
| 12/04/2013 | CN103420917A Benzamide compounds containing fused ring structure and applications thereof as antitumor medicaments |
| 12/04/2013 | CN103420906A Novel tyrosine protein kinase inhibitor |
| 12/04/2013 | CN103420877A Selective hydroxamate-based MMP inhibitors |
| 12/04/2013 | CN103417988A Application of CDK2 gene to preparation of leukemia induced differentiation therapeutic drug |
| 12/04/2013 | CN103417986A Application of MTDH to preparation or screening of drugs for curing hyperaldosteronism adenomata or adrenal tumors |
| 12/04/2013 | CN103417985A Application of antisense nucleotide sequences of ribosomal protein analogues RPL22L1 in preparing medicines capable of suppressing growth of ovarian cancer cells |
| 12/04/2013 | CN103417984A Nano dual-drug delivery system for targeting brain gliomas and preparation method thereof |
| 12/04/2013 | CN103417983A Novel apoptosis-related molecule TMEM106A and applications thereof |
| 12/04/2013 | CN103417982A Application of human original longevity assurance gene 2 in preparation of drugs for improving sensitivity of breast cancer cells against anticancer drugs |
| 12/04/2013 | CN103417977A Efficient folate receptor alpha subtype-mediated target drug delivery system |
| 12/04/2013 | CN103417969A Regulator and pharmaceutical composition containing the same |
| 12/04/2013 | CN103417968A Application of poly cytosine binding protein-2 inhibitor to prepare medicaments for treating human glioma |
| 12/04/2013 | CN103417965A Anti-VEGF antibody containing pharmaceutical composition |
| 12/04/2013 | CN103417964A Application of anti-VEGF antibody |
| 12/04/2013 | CN103417956A Application of feedback CIK cell and interleukin-2 in mild moderate dose to combined and sequenced chemotherapy for treating later period non-small cell lung cancer |
| 12/04/2013 | CN103417954A KGF2-containing plant oil body gelling agent |
| 12/04/2013 | CN103417953A Application of recombined ganoderma lucidum immnoregulation protein (rLZ-8) in preparation of medicine for treating melanin tumor |
| 12/04/2013 | CN103417910A Chinese medicine pill for treating uterine fibroid and preparation method thereof |
| 12/04/2013 | CN103417907A Applications of traditional Chinese medicine composition in preparation of drug used for inhibiting angiogenesis |
| 12/04/2013 | CN103417890A Application of stahlianthus involucratus and extractive of stahlianthus involucratus in preparing drugs for treating and/or preventing cancer |
| 12/04/2013 | CN103417889A Application of stahlianthus involucratus and extractive of stahlianthus involucratus in preparing drugs for treating and/or preventing nasopharynx cancer |
| 12/04/2013 | CN103417888A Application of stahlianthus involucratus and extractive of stahlianthus involucratus in preparing drugs for treating and/or preventing liver cancer |
| 12/04/2013 | CN103417877A Cancer treatment and prevention by utilization of herbal medicine |
| 12/04/2013 | CN103417872A TCM composition for treatment of lung cancer and preparation method thereof |
| 12/04/2013 | CN103417864A Method for preparing preparation for treating lung cancer |
| 12/04/2013 | CN103417858A Novel health-preserving oral liquid |
| 12/04/2013 | CN103417845A Traditional Chinese medicine preparation used for preventing and treating postoperative complications of gastric cancer and preparation method thereof |
| 12/04/2013 | CN103417836A Traditional Chinese medicine composition for treating tumor, and preparation method thereof |
| 12/04/2013 | CN103417819A Active lilium extract, and preparation method and application of active lilium extract |
| 12/04/2013 | CN103417810A Traditional Chinese medicine for treating esophagus cancer |
| 12/04/2013 | CN103417767A Method for preparing preparation for treating lung cancer |
| 12/04/2013 | CN103417706A Method for preparing preparation for treating gastric cancer |
| 12/04/2013 | CN103417668A Application of sorbus sibirica fruit extract to preparation of drugs or health care products with HeLa cell resistance |
| 12/04/2013 | CN103417667A Application of herba lycopi for preparation of lung disease specific medicine |
| 12/04/2013 | CN103417624A Health wine for preventing high blood pressure, high cholesterol, high blood sugar, cardiovascular and cerebrovascular diseases and various tumors |
| 12/04/2013 | CN103417620A Application of serrate rabdosia herb extractive serving as STAT3 signal specificity inhibiter in preparation of anti-tumor drug |
| 12/04/2013 | CN103417619A Health-caring liquid for cancer rehabilitation |
| 12/04/2013 | CN103417610A Chinese medicine for treating esophagus cancer |
| 12/04/2013 | CN103417561A Application of paeoniflorin compound in preparation of anti-tumor drug |
| 12/04/2013 | CN103417554A Anti-tumor medicine composition and applications therefor |
| 12/04/2013 | CN103417551A Traditional Chinese medicine compound cancer-attacking liposomal preparation for treating lung cancer and preparation method thereof |
| 12/04/2013 | CN103417550A Application of sterol phenolic ester to preparation of breast cancer prevention and treatment medicine |